Anita Goel to be Featured Luncheon Speaker at FDLI's Annual Nanotechnology Conference

Anita Goel to be Featured Luncheon Speaker at FDLI's Annual Nanotechnology
Conference

Top Government Officials Will Explain Regulatory Plans for Cutting-Edge
Technology at National Meeting Feb. 18-19 in Washington, DC.

WASHINGTON, Feb. 13 /PRNewswire-USNewswire/ -- Anita Goel, M.D., Ph.D., the
founder of Nanobosym, Inc., and Harvard-MIT-trained physicist and physician
will deliver the featured luncheon address Feb. 19, 2009 at FDLI's 2nd Annual
Conference on Nanotechnology Law, Regulation and Policy Feb. 18-19, in
Washington, D.C.

Nanotechnology was incorporated into more than $60 billion in manufactured
goods last year. By 2014, the market will grow to $2.6 trillion. By 2011, over
$15 billion in nano-enabled drugs and therapeutics will be sold--up from more
than $3 billion in 2006. And industry experts project that nanotechnology will
be incorporated into $20 billion worth of consumer food products by 2010.

With this rapid commercialization -- and with a new Administration in power -
all eyes are on federal government regulators to find out how they intend to
deal with this burgeoning issue. FDLI, in partnership with Burdock Group and
Arizona State University, has assembled -- in one forum -- top officials at
the agencies responsible for the regulation of nanotechnology products --
including the Food and Drug Administration and the Environmental Protection
Agency - to discuss their plans for managing and monitoring these products.

FDA speakers include: Norris Alderson, FDA Nanotechnology Task Force; John
Weimer, Office of Chief Counsel; Subhas Malghan, Center for Devices and
Radiological Health; Linda Katz, Center for Food Safety and Applied Nutrition;
Mitchell Cheeseman, Center for Food Safety and Applied Nutrition; and Douglas
Throckmorton, Center for Drug Evaluation and Research.

Jessica Barkas, Program Attorney in the Chemical Control Division of the
Environmental Protection Agency, also will be speaking at the meeting.

At the meeting at the L'Enfant Plaza Hotel, D.C., food and drug industry
representatives also will find out what's happening internationally on
nanotech regulation, how venture capitalists look at the future of
nanotechnology and what the leading corporations, scientific laboratories and
academic centers are focusing on in this dynamic field.

This groundbreaking conference will seek answers to these questions:

-- What progress is FDA making in implementing its Nanotechnology Task
Force Report?
-- What can FDA learn from EPA and other oversight agencies in NNI?
-- Will the heavily Democratic Congress invest in and/or regulate more
than
under the Bush Administration?
-- Are workers exposed to asbestos-like dangers from dealing with nano
products?
-- How does a responsible company devise a risk management plan for
nanotech development -- one that takes into account OSHA and NIOSH
policy?
-- What is reasonable and required federal funding for U.S nanotechnology
R&D, including monies for safety and social policy research?
-- Are China and Japan ahead of the U.S. in nanotech development?
-- For nanotech products and processes, should particle size make a
regulatory difference?

Other featured speakers and moderators include:

Scott Livingston, Capital Management/The Livingston Group
Andrew Maynard, Woodrow Wilson International Center for Scholars
George Burdock, Burdock Group
Tie Lan, NanoCor Inc.
Robert J. Nicolosi, University of Massachusetts, Lowell
Ralph Hall, University of Minnesota Law School
Matthew Jaffe, Crowell & Moring, LLP
Les Makepeace, Colorado Nanotechnology Alliance
Sean Murdock, NanoBusiness Alliance
Jay Ansell, Personal Care Products Council
James Chen, Crowell & Moring, LLP
John Howard, Public Health Law Program, Centers for Disease Control
Jim O'Reilly, Baker & Daniels
Henry Chajet, Patton Boggs
Rachel Lattimore, Arent Fox
John Monica, Porter Wright
Susan Brienza, Patton Boggs
Lynn L. Bergeson, Bergeson & Campbell, P.C.
Don Ewert, Oso BioPharmaceuticals
Michael J. Kosnett, University of Colorado, Denver and Colorado School of
Public Health
Gary Marchant, Arizona State University
Diana Bowman, Monash University
Steffi Friedrichs, Nanotechnology Industries Association
John Pendergrass, Environmental Law Institute
David Guston, Center for Nanotechnology in Society
Jordan Paradise, University of Minnesota Law School
Vickie Sutton, Texas Tech University School of Law

Burdock Group has more than 20 years of expertise regarding ingredient safety
and regulatory consultation services. Burdock Group's team offers
mission-critical services that include Generally Recognized as Safe (GRAS),
New Dietary Ingredient Notifications (NDINs), Consumption Analysis, Claims
substantiation, Toxicology and Risk Assessment, Literature Searches and Label
Reviews. For more information, visit www.BurdockGroup.com.

The Center for the Study of Law, Science & Technology at Arizona State
Universityis the nation's oldest and largest academic center focusing on the
intersection of law with science and technology, and is currently engaged in a
three-year study funded by the DOE on regulation of nanotechnology.

To register for the conference, visit www.fdli.org or call (800) 956-6293 or
(202) 371-1420.

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug
Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books
and publications for attorneys, regulatory affairs practitioners, scientists,
health care professionals, government employees and marketers in the food and
drug field. For more information, visit www.fdli.org

SOURCE Food and Drug Law Institute

Michael Levin-Epstein of the Food and Drug Law Institute, +1-202-222-0897,
mdl@fdli.org